Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?

Journal of Ethnopharmacology

Volumn 179, Issue , 2016, Pages 253-264

  Chen, Feng ^a   Wen, Qi ^a   Jiang, Jun ^a   Li, Hai Long ^a   Tan, Yin Feng ^a   Li, Yong Hui ^a   Zeng, Nian Kai ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Gut microbiota; Herb microbiota interaction; Microbiota availability; Oral bioavailability; Traditional herbs

Indexed keywords

BAICALIN; BERBERINE; DAIDZIN; ELLAGITANNIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GINSENOSIDE; GINSENOSIDE C K; GINSENOSIDE RB 1; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HESPERIDIN; POLYPHENOL DERIVATIVE; POLYSACCHARIDE; PROANTHOCYANIDIN; PROCYANIDIN; RESVERATROL; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ATRACTYLODES MACROCEPHALA; CHEMICAL STRUCTURE; DRUG BIOAVAILABILITY; GYNOSTEMMA PENTAPHYLLUM; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFORMATION RETRIEVAL; INTESTINE FLORA; LONICERA JAPONICA; LONICERAE JAPONICAE; MEDLINE; REVIEW; RHIZOME; TEA; TRAMETES VERSICOLOR; WEB OF SCIENCE; BIOAVAILABILITY; DRUG EFFECTS; HUMAN; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; DRUGS, CHINESE HERBAL; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 84952762385     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.12.031     Document Type: Review

References (136)

1. T. Akao, K. Kawabata, E. Yanagisawa, K. Ishihara, Y. Mizuhara, Y. Wakui, Y. Sakashita, and K. Kobashi Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form J. Pharm. Pharmacol. 52 2000 1563 1568
2. T. Akao, H. Kida, M. Kanaoka, M. Hattori, and K. Kobashi Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng J. Pharm. Pharmacol. 50 1998 1155 1160
3. L. Almeida, M. Vaz da Silva, A. Falcão, E. Soares, R. Costa, A.I. Loureiro, C. Fernandes-Lopes, J.F. Rocha, T. Nunes, L. Wright, and P. Soares-da-Silva Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers Mol. Nutr. Food Res. 53 2009 7 15
4. A. Amaretti, S. Raimondi, A. Leonardi, A. Quartieri, and M. Rossi Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria Nutrients 7 2015 2788 2800
5. M.M. Appeldoorn, J.P. Vincken, A.M. Aura, P.C. Hollman, and H. Gruppen Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites J. Agric. Food Chem. 57 2009 1084 1092
6. U. Axling, C. Olsson, J. Xu, C. Fernandez, S. Larsson, K. Ström, S. Ahrné, C. Holm, G. Molin, A.L. Barabási, N. Gulbahce, and J. Loscalzo Network medicine: a network-based approach to human disease Nat. Rev. Genet. 12 2011 56 68
7. A. Bazylko, J.P. Piwowarski, A. Filipek, J. Bonarewicz, and M. Tomczyk In vitro antioxidant and anti-inflammatory activities of extracts from Potentilla recta and its main ellagitannin, agrimoniin J. Ethnopharmacol. 149 2013 222 227
8. K. Berger Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice Nutr. Metab. 9 2012 105
9. B. Bremer, K. Bremer, M. Chase, M. Fay, J. Reveal, D. Soltis, P. Soltis, and P. Stevens An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III Bot. J. Linn. Soc. 61 2009 105 121
10. F. Cardona, C. Andres-Lacueva, S. Tulipani, F.J. Tinahones, and M.I. Queipo-Ortuno Benefits of polyphenols on gut microbiota and implications in human health J. Nutr. Biochem. 24 2013 1415 1422
11. L.G. Carter, J.A. D'Orazio, and K.J. Pearson Resveratrol and cancer: focus on in vivo evidence Endocr. Relat. Cancer 21 2014 R209 R225
12. C.J. Chang, C.S. Lin, C.C. Lu, J. Martel, Y.F. Ko, D.M. Ojcius, S.F. Tseng, T.R. Wu, Y.Y. Chen, J.D. Young, and H.C. Lai Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota Nat. Commun. 6 2015 7489
13. F. Chen, L. Li, F. Xu, Y. Sun, F. Du, X. Ma, C. Zhong, X. Li, F. Wang, N. Zhang, and C. Li Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration Br. J. Pharmacol. 170 2013 440 457
14. L. Chen, Y. Yang, P. Yuan, Y. Yang, K. Chen, Q. Jia, and Y. Li Immunosuppressive effects of A-type procyanidin oligomers from Cinnamomum tamala Evid. Based Complement. Altern. Med. 2014 2014 365258
15. I. Cho, and M.J. Blaser The human microbiome: at the interface of health and disease Nat. Rev. Genet. 13 2012 260 270
16. J. Chen, H. Wu, Q. Wang, Y. Chang, K. Liu, and W. Wei Ginsenoside metabolite compound K suppresses T-cell priming via modulation of dendritic cell trafficking and costimulatory signals, resulting in alleviation of collagen-induced arthritis J. Pharmacol. Exp. Ther. 353 2015 71 79
17. L. Chen, W.C. Tai, M.S. Brar, F.C. Leung, and W.L. Hsiao Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal gynostemma saponins Plos One 10 2015 e0126807
18. X. Chen, R. D'Souza, and S.T. Hong The role of gut microbiota in the gut-brain axis: current challenges and perspectives Protein Cell 4 2013 403 414
19. F. Cheung TCM: made in China Nature 480 2011 S82 S83
20. T. Clavel, and J.O. Mapesa Phenolics in human nutrition: importance of the intestinal microbiome for isoflavones and lignin bioavailability K.G. Ramawat, J.M. Mérillon, Natural Products, Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes 2013 Springer-Verlag Berlin Heidelberg, Berlin 2433 2463
21. J.C. Clemente, L.K. Ursell, L.W. Parfery, and R. Knight Cell 148 2012 1258 1270
22. P. Cordero, and E.A. Ashley Whole-genome sequencing in personalized therapeutics Clin. Pharmacol. Ther. 91 2012 1001 1009
23. A. Cotillard, S.P. Kennedy, L.C. Kong, E. Prifti, N. Pons, E. Le Chatelier, M. Almeida, B. Quinquis, F. Levenez, N. Galleron, S. Gougis, S. Rizkalla, J.M. Batto, P. Renault, consortium ANR MicroObes, J. Doré, Zucker J.D., K. Clément, and S.D. Ehrlich Dietary intervention impact on gut microbial gene richness Nature 500 2013 585 588
24. C.A. Cunha, F.S. Lira, Neto, J.C. Rosa, G.D. Pimentel, G.I. Souza, C.M. da Silva, C.T. de Souza, E.B. Ribeiro, A.C. Sawaya, C.M. Oller do Nascimento, B. Rodrigues, P. de Oliveira Carvalho, and L.M. Oyama Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet Mediat. Inflamm. 2013 635470
25. U. Etxeberria, N. Arias, N. Boqué, M.T. Macarulla, M.P. Portillo, J.A. Martínez, and F.I. Milagro Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats J.Nutr. Biochem. 26 2015 651 660
26. R. Feng, J.W. Shou, Z.X. Zhao, C.Y. He, C. Ma, M. Huang, J. Fu, X.S. Tan, X.Y. Li, B.Y. Wen, X. Chen, X.Y. Yang, G. Ren, Y. Lin, Y. Chen, X.F. You, Y. Wang, and J.D. Jiang Transforming berberine into its intestine-absorbable form by the gut microbiota Sci. Rep. 5 2015 12155
27. A.F. Fernández, and M.F. Fraga The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan Epigenetics 6 2011 870 874
28. H.J. Flint, K.P. Scott, P. Louis, and S.H. Duncan The role of the gut microbiota in nutrition and health Nat. Rev. Gastroenterol. Hepatol. 9 2012 577 589
29. C. Garcia-Muñoz, and F. Vaillant Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods Crit. Rev. Food Sci. Nutr. 54 2014 1584 1598
30. C. Giorgio, P. Mena, D. Del Rio, F. Brighenti, E. Barocelli, I. Hassan-Mohamed, D. Callegari, A. Lodola, and M. Tognolini The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells Mol. Nutr. Food Res. 59 2015 2155 2167
31. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin. Biochem. 36 2003 79 87
32. L. Guadamuro, S. Delgado, B. Redruello, A.B. Flórez, A. Suárez, P. Martínez-Camblor, and B. Mayo Equol status and changes in fecal microbiota in menopausal women receiving long-term treatment for menopause symptoms with a soy-isoflavone concentrate Front. Microbiol. 6 2015 777
33. M.Z. Guo, S. Ding, C.H. Zhao, X.X. Gu, X.Y. He, K.L. Huang, Y. Luo, Z. Liang, H. Tian, and W. Xu Red ginseng and semen coicis can improve the structure of gut microbiota and relieve the symptoms of ulcerative colitis J. Ethnopharmacol. 162 2015 7 13
34. J. Han, L.C.M. Antunes, B.B. Finlay, and C.H. Borchers Metabolomics: towards understanding host-microbe interactions Future Microbiol. 5 2010 153 161
35. J. Han, H. Lin, and W. Huang Modulating gut microbiota as an anti-diabetic mechanism of berberine Med. Sci. Monit. 17 2011 RA164 RA167
36. Y.H. Hong, Y. Nishimura, D. Hishikawa, H. Tsuzuki, H. Miyahara, C. Gotoh, K.C. Choi, D.D. Feng, C. Chen, H.G. Lee, K. Katoh, S.G. Roh, and S. Sasaki Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43 Endocrinology 146 2005 5092 5099
37. A.L. Hopkins, and C.R. Groom The druggable genome Nat. Rev. Drug Discov. 1 2002 727 730
38. L. Hood, J.R. Heath, M.E. Phelps, and B.Y. Lin Systems biology and new technologies enable predictive and preventative medicine Science 306 2004 640 643
39. W. Hua, L. Ding, Y. Chen, B. Gong, J. He, and G. Xu Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry J. Pharm. Biomed. Anal. 44 2007 931 937
40. K. Igami, Y. Shimojo, H. Ito, T. Miyazaki, and Y. Kashiwada Hepatoprotective effect of fermented ginseng and its major constituent compound K in a rat model of paracetamol (acetaminophen)-induced liver injury J. Pharm. Pharmacol. 67 2015 565 572
41. S. Jiang., D. Ren, J. Li, G. Yuan, H. Li, G. Xu, X. Han, P. Du, and L. An Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus Fitoterapia 95 2014 58 64
42. J.S. Jin, M. Touyama, T. Hisada, and Y. Benno Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species Microbiol. Immunol. 56 2012 729 739
43. N. Kamada, G.Y. Chen, N. Inohara, and G. Núñez Control of pathogens and pathobionts by the gut microbiota Nat. Immunol. 14 2013 685 690
44. N. Kamada, S.U. Seo, G.Y. Chen, and G. Núñez Role of the gut microbiota in immunity and inflammatory disease Nat. Rev. Immunol. 13 2013 321 335
45. K.A. Kang, M.J. Piao, K.C. Kim, J. Zheng, C.W. Yao, J.W. Cha, H.S. Kim, D.H. Kim, S.C. Bae, and J.W. Hyun Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity Int. J. Oncol. 43 2013 1907 1914
46. M.J. Kang, G.S. Ko, Oh do, G. Kim, J.S. Noh, K. Kang, W. Yoon, W.K. Kim, H.C. Jeong, and H.G. Jeong, T.C. Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin Arch. Pharm. Res. 37 2014 371 378
47. B.S. Kim, M.Y. Song, and H. Kim The anti-obesity effect of Ephedra sinica through modulation of gut microbiota in obese Korean women J. Ethnopharmacol. 152 2014 532 539
48. C.K. Kim, M. Kim, S.D. Oh, S.M. Lee, B. Sun, G.S. Choi, S.K. Kim, H. Bae, C. Kang, and B.I. Min Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity J. Ethnopharmacol. 137 2011 396 402
49. H.S. Kim, M.J. Quon, and J.A. Kim New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate Redox Biol. 2 2014 187 195
50. K.A. Kim, I.H. Jung, S.H. Park, Y.T. Ahn, C.S. Huh, and D.H. Kim Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K Plos One 8 2013 e62409
51. Y.S. Kim, J.J. Kim, K.H. Cho, W.S. Jung, S.K. Moon, E.K. Park, and D.H. Kim Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells J. Microbiol. Biotechnol. 18 2008 1109 1114
52. S.J. Ko, G. Han, S.K. Kim, J.G. Seo, W.S. Chung, B. Ryu, J. Kim, I. Yeo, B.J. Lee, J.M. Lee, and J.W. Park Effect of korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial Evid. Based Complement. Altern. Med. 2013 2013 824605
53. S.J. Ko, B. Ryu, J. Kim, B.G. Hong, I. Yeo, B.J. Lee, J.M. Lee, and J.W. Park Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial Trials 12 2011 219
54. P. Kohl, E.J. Crampin, T.A. Quinn, and D. Noble Systems biology: an approach Clin. Pharmacol. Ther. 88 2010 25 33
55. K.P. Latté, M. Kaloga, A. Schäfer, and H. Kolodziej An ellagitannin, n-butyl gallate, two aryltetralin lignans, and an unprecedented diterpene ester from Pelargonium reniforme Phytochemistry 69 2008 820 826
56. A.L. Lee, J.H. Dou, R. Agarwal, R. Temple, J. Beitz, C. Wu, A. Mulberg, L.X. Yu, and J. Woodcock Evolution of traditional medicines to botanical drugs Science 347 2015 S32 S34
57. E.L.H. Leung, V.K.W. Wong, Z.H. Jiang, T. Li, and L. Liu Integrated network-based medicine: The role of traditional Chinese medicine in developing a new generation of medicine Science 346 2014 S16 S18
58. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023
59. P. Louis, G.L. Hold, and H.J. Flint The gut microbiota, bacterial metabolites and colorectal cancer Nat. Rev. Microbiol. 12 2014 661 672
60. X. Li, G. Wang, J. Sun, H. Hao, Y. Xiong, B. Yan, Y. Zheng, and L. Sheng Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats Biol. Pharm. Bull. 30 2007 847 851
61. A. Lindstrom, C. Ooyen, M.E. Lynch, M. Blumenthal, and K. Kawa Sales of herbal dietary supplements increase by 7.9% in 2013, marking a decade of rising sales: turmeric supplements climb to top ranking in natural channel HerbalGram 103 2014 52 56
62. X. Lin, Z. Wang, G. Sun, L. Shen, D. Xu, and Y. Feng A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats Biomed. Chromatogr. 24 2010 820 825
63. C. Lipinski, F. Lombardo, B. Dominy, and P. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
64. H.P. Liu, J.L. Yang, F.F. Du, X.M. Gao, X.T. Ma, Y.H. Huang, F. Xu, W. Niu, F.Q. Wang, Y. Mao, Y. Sun, T. Lu, C.X. Liu, B.L. Zhang, and C. Li Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats Drug Metab. Dispos. 37 2009 2290 2298
65. T.M. Liu, and X.H. Jiang Investigation of the absorption mechanisms of baicalin and baicalein in rats J. Pharm. Sci. 95 2006 1326 1333
66. Y. Liu, H. Hao, H. Xie, H. Lv, C. Liu, and G. Wang Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats J. Pharm. Sci. 98 2009 4391 4401
67. J.Y. Ma, X. Zhou, J. Fu, T. Hu, P.M. Or, R. Feng, C.Y. He, W.J. Chen, X. Zhang, Y. Chen, Y. Wang, and J.H. Yeung Metabolite profiling analysis of FR429, an ellagitannin purified from Polygonum capitatum, in rat and human liver microsomes, cytosol and rat primary hepatocytes in vitro Chem. Biol. Interact. 220 2014 33 40
68. S. Maccaferri, E. Biagi, and P. Brigidi Metagenomics: key to human gut microbiota Dig. Dis. 29 2011 525 530
69. L. Marín, E.M. Miguélez, C.J. Villar, and F. Lombó Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties Biomed. Res. Int. 2015 2015 905215
70. R. Martín, S. Miquel, P. Langella, and L.G. Bermúdez-Humarán The role of metagenomics in understanding the human microbiome in health and disease Virulence 5 2014 413 423
71. A. Matthies, G. Loh, M. Blaut, and A. Braune Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats J. Nutr. 142 2011 40 46
72. D. Mereles, and W. Hunstein Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int. J. Mol. Sci. 12 2011 5592 5603
73. C.H. Nakatsu, A. Armstrong, A.P. Clavijo, B.R. Martin, S. Barnes, and C.M. Weaver Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption Plos One 9 2015 e108924
74. T. Nunes, L. Almeida, J.F. Rocha, A. Falcão, C. Fernandes-Lopes, A.I. Loureiro, L. Wright, M. Vaz-da-Silva, and P. Soares-da-Silva Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects J. Clin. Pharmacol. 49 2009 1477 1482
75. A.M. O'Hara, and F. Shanahan The gut flora as a forgotten organ EMBO Rep. 7 2006 688 693
76. K. Ou, P. Sarnoski, K.R. Schneider, K. Song, C. Khoo, and L. Gu Microbial catabolism of procyanidins by human gut microbiota Mol. Nutr. Food Res. 58 2014 2196 2205
77. K. Pallav, S.E. Dowd, J. Villafuerte, X. Yang, T. Kabbani, J. Hansen, M. Dennis, D.A. Leffler, D.S. Newburg, and C.P. Kelly Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial Gut Microbes 5 2014 458 467
78. D. Pan, D. Zhang, J. Wu, C. Chen, Z. Xu, H. Yang, and P. Zhou Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism Plos One 8 2013 e68332
79. J.P. Piwowarski, S. Granica, M. Zwierzyńska, J. Stefańska, P. Schopohl, M.F. Melzig, and A.K. Kiss Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials J. Ethnopharmacol. 155 2014 801 809
80. J. Qiu Back to the future' for Chinese herbal medicines Nat. Rev. Drug Discov. 6 2007 506 507
81. A.G. Ramstead, I.A. Schepetkin, M.T. Quinn, and M.A. Jutila Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFNγ production by lymphocytes Plos One 7 2012 e50546
82. V. Razmovski-Naumovski, T.H.W. Huang, V.H. Tran, G.Q. Li, C.C. Duke, and B.D. Roufogalis Chemistry and pharmacology of Gynostemma pentaphyllum Phytochem. Rev. 4 2005 197 219
83. J.L. Round, and S.K. Mazmanian The gut microbiota shapes intestinal immune responses during health and disease Nat. Rev. Immunol. 9 2009 313 323
84. G. Rose, D.J. Wooldridge, C. Anscombe, E.T. Mee, R.V. Misra, and S. Gharbia Challenges of the unknown: clinical application of microbial metagenomics Int. J. Genom. 2015 2015 292950
85. J.Q. Ruan, S. Li, Y.P. Li, W.J. Wu, M.S. Lee, and R. Yan The presystemic interplay between gut microbiota and orally administered calycosin-7-O-β-d-glucoside Drug Metab. Dispos. 43 2015 1601 1611
86. M. Sajish, and P. Schimmel A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol Nature 519 2015 370 373
87. J.M. Sánchez-Calvo, M.A. Rodríguez-Iglesias, J.M.G. Molinillo, and F.A. Macías Soy isoflavones and their relationship with microflora: beneficial effects on human health in equol producers Phytochem. Rev. 12 2013 979 1000
88. I. Sekirov, S.L. Russell, L.C.M. Antunes, and B.B. Finlay Gut microbiota in health and disease Physiol. Rev. 90 2010 859 904
89. D.B. Seo, H.W. Jeong, D. Cho, B.J. Lee, J.H. Lee, J.Y. Choi, I.H. Bae, and S.J. Lee Fermented green tea extract alleviates obesity and related complications and alters gut microbiota composition in diet-induced obese mice J. Med. Food 18 2015 549 556
90. A. Serra, A. Macià, M.P. Romero, J. Valls, C. Bladé, L. Arola, and M.J. Motilva Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models Br. J. Nutr. 103 2010 944 952
91. L.L. Shi, Y. Li, Y. Wang, and Y. Feng MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice Int. J. Biol. Macromol. 81 2015 576 583
92. L.L. Shi, Y. Wang, and Y. Feng Effect of MDG-1, a polysaccharide from Ophiopogon japonicas, on diversity of lactobacillus in diet-induced obese mice Chin. J. Chin. Mater. Med. 40 2015 716 721
93. P.A. Smith The tantalizing links between gut microbes and the brain Nature 526 2015 312 314
94. M.Y. Song, B.S. Kim, and H. Kim Influence of Panax ginseng on obesity and gut microbiota in obese middle-aged Korean women J. Ginseng Res. 38 2014 106 115
95. M.Y. Song, J.H. Wang, T. Eom, and H. Kim Schisandra chinensis fruit modulates the gut microbiota composition in association with metabolic markers in obese women: a randomized, double-blind placebo controlled study Nutr. Res. 35 2015 655 663
96. M. Stolarczyk, J.P. Piwowarski, S. Granica, J. Stefańska, M. Naruszewicz, and A.K. Kiss Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion Phytother. Res. 27 2013 1842 1848
97. [14C]procyanidin B2 in male rats Drug Metab. Dispos. 38 2010 287 291
98. S. Stoupi, G. Williamson, J.W. Drynan, D. Barron, and M.N. Clifford A comparison of the in vitro biotransformation of (-)-epicatechin and procyanidin B2 by human faecal microbiota Mol. Nutr. Food Res. 54 2010 747 759
99. M. Tamura, S. Hori, H. Nakagawa, K. Katada, K. Kamada, K. Uchiyama, O. Handa, T. Takagi, Y. Naito, and T. Yoshikawa Relationships among fecal daidzein metabolites, dietary habit and BMI in healthy volunteers: a preliminary study Biosci. Microbiota Food Health 34 2015 59 65
100. J.L. Tang Research priorities in traditional Chinese medicine BMJ 333 2006 391 394
101. R. Verpoorte Good practices 2012. The basis for evidence-based medicines J. Ethnopharm. 140 2012 456 457
102. E. Theodoratou, H. Campbell, N.T. Ventham, D. Kolarich, M. Pučić-Baković, V. Zoldoš, D. Fernandes, I.K. Pemberton, I. Rudan, N.A. Kennedy, M. Wuhrer, E. Nimmo, V. Annese, D.P. McGovern, J. Satsangi, and G. Lauc The role of glycosylation in IBD Nat. Rev. Gastroenterol. Hepatol. 11 2014 588 600
103. V.H. Thomas, S. Bhattachar, L. Hitchingham, P. Zocharski, M. Naath, N. Surendran, C.L. Stoner, and A. El-Kattan The road map to oral bioavailability: an industrial perspective Expert Opin. Drug Metab. Toxicol. 2 2006 591 608
104. A. Thyagarajan-Sahu, B. Lane, and D. Sliva ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK BMC Complement. Altern. Med. 11 2011 74
105. J. Tomé-Carneiro, M. Larrosa, A. González-Sarrías, F.A. Tomás-Barberán, M.T. García-Conesa, and J.C. Espín Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence Curr. Pharm. Des. 19 2013 6064 6093
106. Y. Tousen, M. Uehara, F. Abe, Y. Kimira, and Y. Ishimi Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study Nutr. J. 12 2013 127
107. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
108. O. Vang, N. Ahmad, C.A. Baile, J.A. Baur, K. Brown, A. Csiszar, D.K. Das, D. Delmas, C. Gottfried, H.Y. Lin, Q.Y. Ma, P. Mukhopadhyay, N. Nalini, J.M. Pezzuto, T. Richard, Y. Shukla, Y.J. Surh, T. Szekeres, T. Szkudelski, T. Walle, and J.M. Wu What is new for an old molecule? Systematic review and recommendations on the use of resveratrol Plos One 6 2011 e19881
109. A.W. Walker, and J. Parkhill Microbiology. Fighting obesity with bacteria Science 341 2013 1069 1070
110. T. Walle Bioavailability of resveratrol Ann. N. Y. Acad. Sci. 1215 2011 9 15
111. H.Y. Wang, L.W. Qi, C.Z. Wang, and P. Li Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on the ginsenosides Am. J. Chin. Med. 39 2011 1103 1115
112. J.H. Wang, S. Bose, G.C. Kim, S.U. Hong, J.H. Kim, J.E. Kim, and H. Kim Flos Lonicera ameliorates obesity and associated endotoxemia in rats through modulation of gut permeability and intestinal microbiota Plos One 9 2014 e86117
113. J.H. Wang, S. Bose, H.G. Kim, K.S. Han, and H. Kim Fermented Rhizoma Atractylodis Macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats Sci. Rep. 5 2015 8391
114. L.Y. Wang, S. Wang, Y. Wang, K.F. Ruan, and Y. Feng Effect of MDG-1 on oral glucose tolerance and intestinal microecological balance in diabetic mice World Chin. J. Dig. 19 2011 2058 2062
115. W.L. Wang, S.Y. Xu, Z.G. Ren, L. Tao, J.W. Jiang, and S.S. Zheng Application of metagenomics in the human gut microbiome World J. Gastroenterol. 21 2015 803 814
116. E. Wenzel, and V. Somoza Metabolism and bioavailability of trans-resveratrol Mol. Nutr. Food Res. 49 2005 472 481
117. C.M. Witt, J.P. Liu, and N. Robinson Combining 'omics and comparative effectiveness research: Evidence-based clinical research decision-making for Chinese medicine Science 347 2015 S50 S51
118. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice Plos One 6 2011 e24520
119. Y. Xiong, N. Miyamoto, K. Shibata, M.A. Valasek, T. Motoike, R.M. Kedzierski, and M. Yanagisawa Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41 Proc. Natl. Acad. Sci. USA 101 2004 1045 1050
120. X.F. Xu, H.D. Yan, and X.W. Zhang Structure and immuno-stimulating activities of a new heteropolysaccharide from Lentinula edodes J. Agric. Food Chem. 60 2012 11560 11566
121. X.F. Xu, and X.W. Zhang Lentinula edodes-derived polysaccharide alters the spatial structure of gut microbiota in mice Plos One 10 2015 e0115037
122. C.S. Yang, X. Wang, G. Lu, and S.C. Picinich Cancer prevention by tea: animal studies, molecular mechanisms and human relevance Nat. Rev. Cancer 9 2009 429 439
123. M.A. YIldIrIm, K.I. Goh, M.E. Cusick, A.L. Barabási, and M. Vidal Drug - target network Nat. Biotechnol. 25 2007 1119 1126
124. J.S. Yim, Y.S. Kim, S.K. Moon, K.H. Cho, H.S. Bae, J.J. Kim, E.K. Park, and D.H. Kim Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora Biol. Pharm. Bull. 27 2004 1580 1583
125. H.J. Yoo, H.J. Kang, Y.S. Song, E.H. Park, and C.J. Lim Anti-angiogenic, antinociceptive and anti-inflammatory activities of Lonicera japonica extract J. Pharm. Pharmacol. 60 2008 779 786
126. K. Yu, F. Chen, and C. Li Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr. Drug. Metab. 13 2012 577 598
127. Z.T. Yu, B. Liu, P. Mukherjee, and D.S. Newburg Trametes versicolor extract modifies human fecal microbiota composition in vitro Plant Foods Hum. Nutr. 68 2013 107 112
128. C.H. Zhang, G.L. Xu, Y.H. Liu, Y. Rao, R.Y. Yu, Z.W. Zhang, Y.S. Wang, and L. Tao Anti-diabetic activities of Gegen Qinlian Decoction in high-fat diet combined with streptozotocininduced diabetic rats and in 3T3-L1 adipocytes Phytomedicine 20 2013 221 229
129. H. Zhang, J. Wei, R. Xue, J.D. Wu, W. Zhao, Z.Z. Wang, S.K. Wang, Z.X. Zhou, D.Q. Song, Y.M. Wang, H.N. Pan, W.J. Kong, and J.D. Jiang Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression Metabolism 59 2010 285 292
130. X. Zhang, Y.F. Zhao, J. Xu, Z.S. Xue, M.H. Zhang, X.Y. Pang, X.J. Zhang, and L.P. Zhao Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats Sci. Rep. 5 2015 14405
131. X. Zhang, Y.F. Zhao, M.H. Zhang, X.Y. Pang, J. Xu, C.Y. Kang, M. Li, C.H. Zhang, Z.G. Zhang, Y.F. Zhang, X.Y. Li, G. Ning, and L.P. Zhao Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats Plos One 7 2012 e42529
132. Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, G. Ren, and G. Ning Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine J. Clin. Endocrinol. Metab. 93 2008 2559 2565
133. L.P. Zhao The gut microbiota and obesity: from correlation to causality Nat. Rev. Microbiol. 11 2013 639 647
134. L.P. Zhao, J.K. Nicholson, A.P. Lu, Z.T. Wang, H.R. Tang, E. Holmes, J. Shen, X. Zhang, J.V. Li, and J.C. Lindon Targeting the human genome-microbiome axis for drug discovery: inspirations from global systems biology and traditional chinese medicine J. Proteome Res. 11 2012 3509 3519
135. L.P. Zhao, and J. Shen Whole-body systems approaches for gut microbiota-targeted, preventive healthcare J. Biotechnol. 149 2010 183 190
136. Z.Z. Zheng, Y.L. Ming, L.H. Chen, G.H. Zheng, S.S. Liu, and Q.X. Chen Compound K-induced apoptosis of human hepatocellular carcinoma MHCC97-H cells in vitro Oncol. Rep. 32 2014 325 331